Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
Guillain-Barre syndrome masquerading as acute respiratory failure in an infant.
A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures.
Clinical and pathological features of acute optic neuritis in Chinese patients.
Effects of a resistance training program and subsequent detraining on muscle strength and muscle power in multiple sclerosis patients.
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
A Pilot Study: examining the effects and tolerability of structured dance intervention for individuals with multiple sclerosis.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity.
MHC Mismatch Results in Neural Progenitor Cell Rejection Following Spinal Cord Transplantation in a Model of Viral-Induced Demyelination.
Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.
An organotypic spinal cord slice culture model to quantify neurodegeneration.
Pharmacodynamic models for discrete data.
Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4.
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography.
Novel Agents for Relapsing Forms of Multiple Sclerosis.
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.
Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis.
Deleterious versus protective autoimmunity in multiple sclerosis.
Demyelination and other neurological adverse events after anti-TNF therapy.
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosis.
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis.
Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.

Pages